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Abstract: The factors determining the presentation of celiac disease are unclear. We investigated the
phenotypic concordance and the distribution of human leukocyte antigen (HLA) risk haplotypes
in affected siblings. One hundred sibling pairs were included. Clinical and histological parameters
and HLA haplotypes were compared between the first diagnosed indexes and their siblings.
The phenotype was categorized into gastrointestinal, extra-intestinal, malabsorption/anemia,
and asymptomatic. The phenotype was fully concordant in 21 pairs. The most common concordant
phenotype was gastrointestinal (14 pairs). Indexes had more anemia/malabsorption and extra-
intestinal symptoms than siblings (45% vs. 20%, p < 0.001 and 33% vs. 12%, p < 0.001, respectively).
Twenty siblings and none of the indexes were asymptomatic. The indexes were more often women
(81% vs. 63%, p = 0.008). They were also more often seronegative (11% vs. 0%, p = 0.03) and younger
(37 vs. 43 year, p < 0.001), and had more severe histopathology (total/subtotal atrophy 79% vs.
58%, p = 0.047) at diagnosis. The indexes and siblings were comparable in other disease features.
Pairs with discordant presentation had similar HLA haplotypes more often than the concordant pairs.
The phenotype was observed to vary markedly between siblings, with the indexes generally having a
more severe presentation. HLA did not explain the differences, suggesting that non-HLA genes and
environmental factors play significant roles.
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1. Introduction
Celiac disease is an immune-mediated condition with an estimated prevalence of 1–2% in Western
countries [1–3]. The first-degree relatives of patients have approximately 2–10 times the average
risk for the disease, whereas in identical twins the concordance rate can be as high as 80% [4–6].
Human leukocyte antigen (HLA) DQ2 and DQ8 haplotypes have been identified as the main genetic
risk factors, without which celiac disease is very unlikely [7]. At population level, approximately
40% of individuals have these risk haplotypes, but only a fraction of them will eventually develop
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the disease [2,7]. This might be partly explained by the effect of non-HLA genes, but considerable
differences in the prevalence between genetically similar populations and the rising true incidence
support the additional role of environmental factors [3,8,9].
In recent decades, we have also come to appreciate that the phenotype of celiac disease is very
heterogeneous. The classical presentation with malabsorption and failure to thrive in early childhood
has become rare. Nowadays, patients often have different gastrointestinal or extra-intestinal symptoms
that may appear at any age, or they can even be completely asymptomatic [10–12]. The reason for
this phenotypic diversity remains obscure [13–17], but the observed variability even between identical
twins suggests that it is not solely determined by genetics [5,18]. Overall, the concordance of the
clinical picture between affected relatives has been scarcely studied. This information could improve
our understanding of the complex interactions between genetic and environmental factors in celiac
disease, and possibly increase the diagnostic yield of this markedly under-recognized condition [3].
In this study, we aimed to evaluate the concordance of the clinical and histological presentation
and the HLA risk haplotypes of untreated celiac disease in close relatives who both have the disease.
Specifically, the comparisons were made between the first affected index patients and their siblings,
who usually have/had a shared environment in childhood and are genetically markedly similar [6].
2. Materials and Methods
2.1. Patients and Study Design
The study was carried out in Finland at the University of Tampere and Tampere University
Hospital. Previously diagnosed celiac disease patients and their relatives were invited to participate
through advertisements in newspapers and via local celiac societies. All participants were interviewed
by a study nurse or physician with expertise in celiac disease, and blood samples were drawn for
further serological and genetic analyses between 2006–2010. Relatives with new celiac autoantibody
positivity were referred to the local hospital for diagnostic endoscopy. In addition to the interview,
the medical records of the patients were surveyed to confirm the diagnosis and to supplement the
clinical, histological, and serological data at diagnosis. Diagnosis had to be based on the demonstration
of villous atrophy in duodenal biopsy in both children and adults. The exclusion criteria were study
refusal and unclear celiac disease diagnosis.
Altogether, 1035 patients and 3031 of their relatives from 732 families were enrolled (Figure 1).
Among the 3031 relatives, 148 new cases of celiac disease were detected by screening. Thus,
1183 subjects had either previously diagnosed or newly diagnosed celiac disease. Of this number,
263 were excluded due to insufficient data for the study analyses. Of the remaining 920 patients,
only families with at least two affected subjects (n = 492) entered the next stage. In order to simplify the
statistical evaluation, only two first-affected siblings from families with multiple cases were enrolled.
The final study group comprised 200 subjects (100 sibling pairs) who underwent comparison for all
study variables as described below (Figure 1). The first diagnosed subject is defined as the index and
the later diagnosed subject is defined as the sibling. The 200 patients included in the final analyses
were diagnosed between the years 1972–2009.
2.2. Clinical Characteristics
The clinical information collected included demographic data and the family history of celiac
disease, the main disease presentation/reason for disease suspicion, and the possible presence of
co-existing autoimmune conditions, fractures, and malignancies.
For the purposes of the study, the clinical presentation at diagnosis was categorized as follows:
malabsorption or anemia, gastrointestinal symptoms, extra-intestinal symptoms, or asymptomatic.
Malabsorption was defined as weight loss and/or characteristic laboratory abnormalities, such as
low folate or hypoalbuminemia. Gastrointestinal symptoms included abdominal pain, diarrhea,
constipation, heartburn, and dysphagia. Extra-intestinal manifestations included dermatitis
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herpetiformis, recurrent aphthous stomatitis, enamel damage as confirmed by a dentist, failure to thrive
(pediatric diagnosis), ataxia, unspecific arthritis, and elevated liver enzymes that were normalized
by a gluten-free diet [19]. Non-specific and/or vague symptoms such as fatigue, infertility, back
pain, and headache were disregarded. A patient could have had several symptoms simultaneously at
diagnosis and thus be included in several symptom groups.Nutrients 2019, 9, x FOR PEER REVIEW  3 of 11 
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also recorded and further divided into ≤5 years and >5 years.  
2.3. Histology 
The results of the histopathologic evaluation of the small-bowel mucosal biopsies were collected 
from patient records. According to our national guidelines, at least four representative biopsies are 
routinely taken from the duodenum in cases of suspected celiac disease [20]. Only correctly orientated 
cuttings are accepted for precise morphometric evaluation [21]. The diagnosis of celiac disease is 
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The diagnostic delay, defined as the duration of possible symptoms before the diagnosis, was also
recorded and further divided into ≤5 years and >5 years.
2.3. Histology
The results of the histopathologic evaluation of the small-bowel mucosal biopsies were collected
from patient records. According to our national guidelines, at least four representative biopsies
are routinely taken from the duodenum in cases of suspected celiac disease [20]. Only correctly
orientated cuttings are accepted for precise morphometric evaluation [21]. The diagnosis of celiac
disease is based on the demonstration of either total, subtotal, or partial villous atrophy, comparable
to the Marsh–Oberhuber classifications IIIa, IIIb, and IIIc, respectively [22]. In cases of dermatitis
herpetiformis, the diagnosis is based on demonstration of granular IgA deposits in the papillary dermis
by direct immunofluorescence examination in a skin biopsy [20].
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2.4. Serology and Genetics
Information on possible earlier determined celiac disease autoantibodies was obtained from
patient records. In addition, serum endomysial (EmA) and tissue transglutaminase antibodies
(tTGab) were measured in all participants from the blood samples taken at the study visit. EmA was
measured by the indirect immunofluorescence method as previously described [20] and titers 1:≥5
were considered positive. A commercial ELISA test (QUANTA Lite h-tTG IgA, INOVA Diagnostics,
San Diego, CA, USA) was used to test tTGab, with a cut-off of >30.0 U/l for seropositivity according to
the manufacturer’s instructions. In cases of IgA deficiency, the autoantibodies were determined by
IgG class.
Genotyping for celiac disease-associated HLA alleles was performed with the SSPTM DQB1
low-resolution kit (Olerup SSP AB, Saltsjöbaden, Sweden) and/or tagging SNP approach [23].
Haplotypes were categorized into HLA DQ2 positives (DQ2.5/DQX or DQ2.2/DQ7), HLA DQ8
positives (DQ8/DQX), and both DQ2 and DQ8 negatives.
2.5. Statistical Analyses
Statistical analyses were performed using SPSS Statistics for Windows (IBM Corp. Armonk,
NY, USA) and STATA Statistical Software (StataCorp. LP, Lakeway Drive, TX, USA). Categorical
variables were studied by McNemar and Chi-Squared tests and continuous variables were studied by
the Wilcoxon signed rank test. A p-value < 0.05 was considered statistically significant.
2.6. Ethics
The study design and patient enrolment was accepted by the Ethics Committee of Pirkanmaa
Hospital District. The study protocol follows the ethical guidelines of the Declaration of Helsinki.
All participants gave written informed consent.
3. Results
3.1. Clinical Data
Twenty-four (12%) of the later diagnosed siblings were diagnosed in the present study. Twenty-six
(13%) of the 200 patients were <18 years of age (range 5–17 years) at the time of the study and 37 (19%)
of the 200 patients were <18 years of age (range 2–17 years) at diagnosis. Of the latter 37 subjects,
21 were first diagnosed and 16 later diagnosed siblings. Among the sibling pairs, there was only one
dizygotic twin pair and no identical twins. The index patients were significantly younger at diagnosis
and more often females compared to the later diagnosed siblings (Table 1). Gastrointestinal symptoms
were the most common and equally distributed presentation was observed in both groups, but the
indexes had malabsorption/anemia and extra-intestinal symptoms significantly more often (Table 1).
Five index patients and 42 siblings were detected by screening; twenty were asymptomatic, all of them
siblings. Seven of the asymptomatic patients were <18 years of age at diagnosis. The index subjects
had more severe histological damage (less partial and more subtotal villous atrophy) and were more
often seronegative at diagnosis, whereas the groups did not differ in terms of current age, length of
diagnostic delay, or the presence of fractures, malignancies, and autoimmune comorbidities (Table 1).
When looking at the whole study cohort, patients suffering from malabsorption or anemia had more
severe villous atrophy compared to the asymptomatic subjects (total 33% vs. 28%, subtotal 50% vs.
22% and partial 17% vs. 50%, p = 0.012, respectively).
Among all subjects, the most common gastrointestinal symptom was diarrhea (43%) and the
most common extra-intestinal symptom was dermatitis herpetiformis (17%). When comparing the
symptom subgroups between the siblings, diarrhea (42% vs. 44%, p = 0.878), abdominal pain (45% vs.
34%, p = 0.117), and constipation (6% vs. 5%, p = 1.000) were equally presented among the indexes
and siblings, as were oral symptoms (4% vs. 1%, p = 0.375) and failure to thrive (7% vs. 3%, p = 0.289).
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Dermatitis herpetiformis was more common among the index patients than among the siblings (25%
vs. 9%, p = 0.002). None of the study subjects had ataxia, arthritis, or elevated liver enzymes.
Table 1. Diagnostic characteristics and presence of complications and comorbidities in 100 sibling pairs
with celiac disease.
Index Patients, n = 100 Siblings, n = 100 p Value
Age at diagnosis, median (Q1, Q3), year 37 (22, 47) 43 (25, 52) <0.001
Age at study visit, median (Q1, Q3), year 52 (38, 59) 51 (36, 58) 0.704
Female, % 81 63 0.008
Diagnostic delay 1, % 0.073
>5 years 44 27
≤5 years 56 74
Clinical presentation at diagnosis, % 2
Gastrointestinal 80 75 0.215
Malabsorption or anemia 45 20 <0.001
Extra-intestinal 33 12 <0.001
Asymptomatic 0 20 <0.001
Degree of villous atrophy at diagnosis, % 0.047
Total 29 27
Subtotal 49 31
Partial 20 41
Positive celiac antibodies at diagnosis 3, % 89 100 0.030
Fractures, % 24 21 0.736
Malignancy 4, % 4 5 1.000
Associated diseases, %
Thyroidal disease 20 9 0.052
Type 1 diabetes 1 4 0.375
Sjögren’s syndrome 2 1 1.000
IgA deficiency 1 0 1.000
1 Duration of symptoms before the diagnosis. Asymptomatic patients excluded. 2 Symptomatic patients could
have had several overlapping presentations. 3 Tissue transglutaminase, endomysium, or reticulin antibodies.
Data missing from 33 indexes and 23 siblings. Comparison made between 54 pairs. 4 For example, breast and
thyroidal cancer.
Altogether, 21 pairs were concordant and 79 pairs were discordant for the celiac disease phenotype,
as defined in the present study (Table 2). Gastrointestinal symptoms represented the most common
concordant phenotype, and it was observed in 14 of the 21 pairs with concordant disease manifestation.
Regarding partial concordance, in 28 pairs the index subject suffered simultaneous gastrointestinal
symptoms and malabsorption/anemia and/or extra-intestinal symptoms, while the sibling had only
gastrointestinal symptoms. Conversely, in nine pairs the sibling had both gastrointestinal and other
symptoms, while the index suffered only gastrointestinal symptoms.
Table 2. Phenotype concordances at celiac disease diagnosis in 100 sibling pairs. Results are presented
as numbers of sibling pairs.
Title Index Patients, n = 100
GI MA EI GI + EI MA + EI GI + MA GI + MA + EI
Siblings, n = 100 GI 14 3 3 8 1 13 7
MA 3 1 0 1 0 0 0
EI 0 0 1 0 0 1 0
GI + EI 3 0 2 1 0 3 0
MA + EI 0 0 0 0 0 0 1
GI + MA 6 1 1 1 1 4 0
GI+ MA + EI 0 0 0 0 0 0 0
Asymptomatic 6 4 2 3 0 5 0
GI, gastrointestinal; MA, malabsorption or anemia; EI, extra-intestinal. Pairs with concordant phenotype bolded.
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3.2. Genetics
Celiac disease-related HLA haplotype data was available for 66 pairs (Table 3). The remaining
34 pairs had one or more allele missing from the HLA-typing and were excluded from the haplotype
comparisons. The most common haplotype among both the indexes and siblings was DQ2.5/DQX,
followed by DQ2.5 homozygosity, and DQ2.5/DQ8. The other celiac disease-associated HLA
haplotypes were present only in a small number of individuals. The HLA haplotype was equal
in 46 (70%) out of the 66 pairs (Table 4). Of them, there were 17 pairs with a concordant clinical
presentation, of whom eight pairs (47%) had the same haplotype (DQ2.5/DQX in six pairs). Of the
remaining 49 pairs with a discordant clinical presentation, 38 (78%) had equal haplotype (DQ2.5/DQX
in 19 pairs). This difference in the prevalence of the same haplotypes between pairs with and without
concordant clinical presentation (47% vs. 78%) was statistically significant (p = 0.018).
Table 3. Overall distribution of human leukocyte antigen (HLA) haplotypes in index cases and siblings
with celiac disease. DQX = other than DQ2.5, DQ2.2, DQ7, or DQ8.
HLA Index Patients, n = 66 % Siblings, n = 66 %
DQ2 positive
DQ2.5/DQX 48 53
DQ2.5/DQ2.5 29 21
DQ2.5/DQ8 11 12
DQ2.5/DQ2.2 2 5
DQ2.5/DQ7 3 2
DQ2.2/DQ7 0 2
DQ2 negative, DQ8 positive
DQ8/DQX 2 2
DQ8/DQ8 0 0
DQ8/DQ2.2 2 0
DQ8/DQ7 3 3
DQ2 negative, DQ8 negative 2 3
Table 4. Concordance of human leukocyte antigen (HLA) haplotypes in 66 sibling pairs. Results are
presented as numbers of sibling pairs. Pairs with similar genotype bolded. DQX = other than DQ2.5,
DQ2.2, DQ7, or DQ8.
Index Patients, n = 66
HLA DQ2.5/X
DQ
2.5/2.5
DQ
2.5/8
DQ
2.5/2.2
DQ
2.5/7
DQ
2.2/7
DQ
8/X
DQ
8/8
DQ
8/2.2
DQ
8/7
DQ 2/8
Neg.
Siblings, n = 66
DQ
2.5/X 25 5 1 0 1 0 0 0 0 2 0
DQ
2.5/2.5 2 12 0 0 0 0 0 0 0 0 0
DQ
2.5/8 1 1 6 0 0 0 0 0 0 0 0
DQ
2.5/2.2 2 0 0 1 0 0 0 0 0 0 0
DQ
2.5/7 1 0 0 0 0 0 0 0 0 0 0
DQ
2.2/7 0 0 0 0 1 0 0 0 0 0 0
DQ
8/X 0 0 0 0 0 0 1 0 0 0 0
DQ
8/8 0 0 0 0 0 0 0 0 0 0 0
DQ
8/2.2 0 0 0 0 0 0 0 0 0 0 0
DQ
8/7 0 1 0 0 0 0 0 0 1 0 0
DQ2/8
Neg. 1 0 0 0 0 0 0 0 0 0 1
4. Discussion
We observed substantial phenotypic variation between the first diagnosed indexes and the later
diagnosed siblings with celiac disease. Gastrointestinal symptoms were frequently seen in both
Nutrients 2019, 11, 479 7 of 10
siblings, but they often co-existed with additional randomly distributed extra-intestinal manifestations,
and within a significant portion of the pairs the clinical presentation was completely different. Familial
phenotype concordance has not been previously studied using a similar approach, but some studies
have shown that the intestinal form of celiac disease and dermatitis herpetiformis can occur within
the same family [24,25]. Interestingly, variation in the clinical phenotype is not restricted to celiac
disease, as similar heterogeneity has been reported, for example, in inflammatory bowel disease [26]
and systemic lupus erythematosus [27].
The haplotypes were even more likely to be similar if the siblings were discordant for the
clinical presentation, suggesting that HLA genotype does not predict the clinical outcome. Previously,
Karell et al. investigated the distribution of HLA haplotypes in 110 sibling pairs with dermal and
intestinal celiac disease and, in accord with us, found no significant association with clinical
outcome [25]. Mustalahti et al. studied 28 asymptomatic and symptomatic sibling pairs [13],
while Greco et al. studied 145 patients categorized into 16 separate phenotypes [14], and no
phenotype–HLA haplotype associations were observed in either study. In contrast, there have been
studies reporting the association of non-HLA variants with distinct celiac disease phenotypes [28–30].
For instance, certain genotypes of haptoglobin and CTLA4 have been associated with clinically mild or
silent disease [29,30], whereas a particular interleukin-10 genotype seems to predispose to early-onset
and histologically severe disease [28]. In any case, the role of both HLA and non-HLA risk variants
seems to be at most modest, as supported by the few studies conducted using monozygous twins.
Hervonen et al. investigated the co-occurrence of intestinal disease and dermatitis herpetiformis in six
monozygous twin pairs: three pairs had the concordant phenotype and two pairs had the discordant
phenotype [5]. Bardella et al. reported variance in both the clinical presentation and even the overall
risk of developing the disease in five monozygous twin pairs [18]. In comparison, the age of onset
and the disease risk can also vary between monozygous twins in children with type 1 diabetes [31].
Thus, the limited role of genetics and the additional effect of environmental factors as modifiers of the
disease risk and phenotype seem to be common features in autoimmune diseases.
The environmental factors involved in modulating the celiac disease phenotype and its
development remain undetermined, as does how their effect is mediated. Hitherto, studies have
focused on searching for possible modifiers of general celiac disease risk. For example, high amounts
of gluten and gastrointestinal infections in infancy may increase the risk [32,33], whereas cesarean
section, the age of gluten introduction, and breastfeeding are unlikely to play a role [34–36]. It remains
unclear if these same factors affect the phenotype. One topic of interest relevant here is gut microbiota.
We previously studied the duodenal microbiota of 32 celiac disease patients and observed that the
bacterial profile, as well as the overall richness and diversity of the microbiota, varies depending on the
phenotype [17]. The causality of these findings is difficult to evaluate, particularly since many of the
previously mentioned environmental and genetic factors may affect both the structure and function
of the microbiota [37,38]. In any case, a better understanding of the environmental factors could,
besides further elucidating the pathogenesis, enable the development of interventions to reduce the
disease risk and/or prevent the most severe outcomes. Large multicenter studies including patients
with well-defined phenotypes are likely needed to fully decipher the complex association between
phenotype, genotype, and environmental factors in celiac disease.
The first diagnosed siblings generally had a more severe disease presentation, demonstrated,
for example, by their higher frequency of anemia and advanced villous atrophy. Similarly,
Gudjónsdóttir et al. investigated the severity of symptoms in 105 sibling pairs and reported more
severe symptoms among the indexes [29]. One explanation for the more advanced presentation in
the first diagnosed siblings in the present study could be the longer disease history, even though the
difference was not statistically significant [39]. Celiac disease is likely suspected with a lower threshold
or screened even without apparent symptoms in the non-index siblings with a known family history
for the condition, who can thus have a less severe phenotype despite being diagnosed at a later age.
Another influencing factor could be the higher frequency of females among the indexes, as women
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have been shown to use more health care services compared to men [40]. In any case, the task of
deciphering the factors behind differences in disease severity between siblings is complex, as various
individual aspects may contribute to the timing of the diagnosis and the phenotype. In a broad sense,
we found it important that the later diagnosed siblings had milder disease at diagnosis, as this indicates
that family screening of celiac disease could simultaneously improve the diagnostic yield and prevent
long-term complications due to earlier initiation of dietary treatment.
The main strength of the present study is the large and well-defined study cohort. The limitations
are the subjective nature and challenging definition of the symptoms, plus possible recall bias. In order
to categorize the phenotype as reliably as possible, the most non-specific symptoms were excluded,
and one author made the classification and analyses systemically. However, the original diagnoses
were made by several physicians, who could have had different approaches, for example, to clinical
evaluation and laboratory testing. Altogether, complex interactions between the many confounders, such
as the individual experience of symptoms, the implementation of screening, and differences between
the groups in the ages at diagnosis and the number of subjects diagnosed in childhood, could influence
the ultimate phenotype and were impossible to fully control for statistically. Genetic analysis was also
limited to the assessment of the frequency of known celiac disease HLA risk haplotypes, and thus no
deeper insight into the role of non-HLA genes and gene-to-gene interactions could be attained.
5. Conclusions
In conclusion, we found the clinical presentation of celiac disease to have a wide variation between
the affected siblings, with the indexes generally having a more severe presentation at diagnosis. It is
therefore important for physicians to remember possible atypical presentations, and to suspect the
disease with a low threshold among the patient’s close relatives. Furthermore, HLA did not explain
the differences, suggesting that non-HLA genes and environmental factors play significant roles.
The ultimate reasons for the substantial phenotype variation in celiac disease remain to be determined
in future studies.
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